| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |